Evidence map›Paper›PMID 9064355›Full record

ArticleThe Journal of experimental medicine1996

Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.

Y Guo, Y Wu, S Shinde, M S Sy, A Aruffo, Y Liu

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 106 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. A two-step, two-signal model for the primary activation of precursor helper T cells.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Y GuoMichael Heidelberger Division of Immunology, Department of Pathology, New York University Medical Center, New York 10016, USA.
Y Wu
S Shinde
M S Sy
A Aruffo
Y Liu
Heidelberg University · DE

Funding

HEAT STABLE ANTIGEN, T-CELL RESPONSE, AND TOLERANCER01AI032981 · NIAID · OHIO STATE UNIVERSITY · PI LIU, YANG · 1994 to 2001
$436k
NIAID NIH HHS AI32981
6 · The paper itself

Abstract

The interaction between CD40 ligand and CD40 is critical for activation of T and B cells in vivo. We have recently demonstrated that this interaction rapidly induces a novel costimulatory activity distinct from B7 and independent of CD28. To study the molecular basis of the costimulatory activity, we have produced a novel monoclonal antibody, TM-1, that binds an 85-kilodalton costimulatory molecule rapidly induced by CD40L. Expression cloning reveals that TM-1 binds CD44H. CD44H expressed on Chinese hamster ovary cells has potent costimulatory activity for clonal expansion of T cells isolated from both wild-type mice and these with a targeted mutation of CD28. Thus, CD44H costimulates T cell proliferation by a CD28-independent mechanism. These results revealed that CD44H is a costimulatory molecule rapidly induced by CD40L.

Indexed as

AnimalsAntibodies, MonoclonalCD40 AntigensCD40 LigandCHO CellsCloning, MolecularCricetinaeHyaluronan ReceptorsMembrane GlycoproteinsMiceMice, Inbred C57BLMice, Inbred CBARNA, MessengerSpectrometry, FluorescenceAntibodies, MonoclonalCD40 AntigensCD40 LigandHyaluronan ReceptorsMembrane GlycoproteinsRNA, Messenger

Identifiers

PMID9064355
PMCPMC2192764
OpenAlexW2136421587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.